Menu
Back to Journals » Infection and Drug Resistance » Volume 5 » default
Infection and Drug Resistance
ISSN: 1178-6973
- View all (3276)
- Volume 16, 2023 (587)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Archive: Volume 5, 2012
Current management options for latent tuberculosis: a review
Norton BL, Holland DP
Infection and Drug Resistance 2012, 5:163-173
Published Date: 29 November 2012
Adverse incidents resulting in exposure to body fluids at a UK dental teaching hospital over a 6-year period
Hughes A, Davies L, Hale R, Gallagher JE
Infection and Drug Resistance 2012, 5:155-161
Published Date: 25 October 2012
Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes
Marí Solivellas B, Cabanes Martín T
Infection and Drug Resistance 2012, 5:149-153
Published Date: 16 October 2012
Prevalence of extended-spectrum beta-lactamase-producing bacteria in food
Tham J, Walder M, Melander E, Odenholt I
Infection and Drug Resistance 2012, 5:143-147
Published Date: 16 October 2012
Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance
Chen LF, Anderson DJ, Paterson DL
Infection and Drug Resistance 2012, 5:133-141
Published Date: 24 September 2012
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
Sarovich DS, Price EP, Limmathurotsakul D, Cook JM, Von Schulze AT, Wolken SR, Keim P, Peacock SJ, Pearson T
Infection and Drug Resistance 2012, 5:129-132
Published Date: 22 August 2012
Current management of parainfluenza pneumonitis in immunocompromised patients: a review
Falsey AR
Infection and Drug Resistance 2012, 5:121-127
Published Date: 8 August 2012
Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005
Ako BA, Offianan AT, Johansson M, Penali LK, Nguetta SP, Sibley CH
Infection and Drug Resistance 2012, 5:113-120
Published Date: 1 August 2012
Treatment of dengue fever
Rajapakse S, Rodrigo C, Rajapakse A
Infection and Drug Resistance 2012, 5:103-112
Published Date: 23 July 2012
Clinical update on linezolid in the treatment of Gram-positive bacterial infections
Ager S, Gould K
Infection and Drug Resistance 2012, 5:87-102
Published Date: 25 June 2012
Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB
Chaiyasirinroje B, Aung MN, Moolphate S, Kasetjaroen Y, Rienthong S, Rienthong D, Nampaisan O, Nedsuwan S, Sangchun W, Suriyon N, Mitarai S, Yamada N
Infection and Drug Resistance 2012, 5:79-86
Published Date: 7 May 2012
The effects of daily chlorhexidine bathing on cutaneous bacterial isolates: a pilot study
Soma VL, Qin X, Zhou C, Adler A, Berry JE, Zerr DM
Infection and Drug Resistance 2012, 5:75-78
Published Date: 24 April 2012
High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India
Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Stålsby Lundborg C
Infection and Drug Resistance 2012, 5:65-73
Published Date: 5 April 2012
Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d’Ivoire
Offianan AT, Penali LK, Coulibaly MA, Tiacoh NL, Ako AAB, Adji EG, Coulibaly B, Koffi D, Sarr D, Jambou R, Kone M
Infection and Drug Resistance 2012, 5:53-63
Published Date: 12 March 2012
Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia
Maselli DJ, Fernandez JF, Whong CY, Echevarria K, Nambiar AM, Anzueto A, Restrepo MI
Infection and Drug Resistance 2012, 5:43-51
Published Date: 1 February 2012
Conjunctival sac bacterial flora isolated prior to cataract surgery
Suto C, Morinaga M, Yagi T, Tsuji C, Toshida H
Infection and Drug Resistance 2012, 5:37-41
Published Date: 24 January 2012
Ceftaroline in complicated skin and skin-structure infections
Hernandez PO, Lema S, Tyring SK, Mendoza N
Infection and Drug Resistance 2012, 5:23-35
Published Date: 19 January 2012
Evaluation of the use of piperacillin/tazobactam (Tazocin®) at Hamad General Hospital, Qatar: are there unjustified prescriptions?
Khan FY, Elhiday A, Khudair IF, Yousef H, Omran AH, Alsamman SH, Elhamid M
Infection and Drug Resistance 2012, 5:17-21
Published Date: 13 January 2012
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
Miceli MH, Chandrasekar P
Infection and Drug Resistance 2012, 5:9-16
Published Date: 11 January 2012
Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?
Thaiss WM, Thaiss CC, Thaiss CA
Infection and Drug Resistance 2012, 5:1-8
Published Date: 9 January 2012